Please use this identifier to cite or link to this item:
https://doi.org/10.1038/s42003-023-05045-0
DC Field | Value | |
---|---|---|
dc.title | The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer | |
dc.contributor.author | Yeo, Xun Hui | |
dc.contributor.author | Sundararajan, Vignesh | |
dc.contributor.author | Wu, Zhengwei | |
dc.contributor.author | Phua, Zi Jin Cheryl | |
dc.contributor.author | Ho, Yin Ying | |
dc.contributor.author | Peh, Kai Lay Esther | |
dc.contributor.author | Chiu, Yi-Chia | |
dc.contributor.author | Tan, Tuan Zea | |
dc.contributor.author | Kappei, Dennis | |
dc.contributor.author | Ho, Ying Swan | |
dc.contributor.author | Tan, David Shao Peng | |
dc.contributor.author | Tam, Wai Leong | |
dc.contributor.author | Huang, Ruby Yun-Ju | |
dc.date.accessioned | 2023-06-30T02:47:07Z | |
dc.date.available | 2023-06-30T02:47:07Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Yeo, Xun Hui, Sundararajan, Vignesh, Wu, Zhengwei, Phua, Zi Jin Cheryl, Ho, Yin Ying, Peh, Kai Lay Esther, Chiu, Yi-Chia, Tan, Tuan Zea, Kappei, Dennis, Ho, Ying Swan, Tan, David Shao Peng, Tam, Wai Leong, Huang, Ruby Yun-Ju (2023). The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer. Communications Biology 6 (1). ScholarBank@NUS Repository. https://doi.org/10.1038/s42003-023-05045-0 | |
dc.identifier.issn | 2399-3642 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/242599 | |
dc.description.abstract | <jats:title>Abstract</jats:title><jats:p>AXL is a receptor tyrosine kinase that is often overexpressed in cancers. It contributes to pathophysiology in cancer progression and therapeutic resistance, making it an emerging therapeutic target. The first-in-class AXL inhibitor bemcentinib (R428/BGB324) has been granted fast track designation by the U.S. Food and Drug Administration (FDA) in STK11-mutated advanced metastatic non-small cell lung cancer and was also reported to show selective sensitivity towards ovarian cancers (OC) with a Mesenchymal molecular subtype. In this study, we further explored AXL’s role in mediating DNA damage responses by using OC as a disease model. AXL inhibition using R428 resulted in the increase of DNA damage with the concurrent upregulation of DNA damage response signalling molecules. Furthermore, AXL inhibition rendered cells more sensitive to the inhibition of ATR, a crucial mediator for replication stress. Combinatory use of AXL and ATR inhibitors showed additive effects in OC. Through SILAC co-immunoprecipitation mass spectrometry, we identified a novel binding partner of AXL, SAM68, whose loss in OC cells harboured phenotypes in DNA damage responses similar to AXL inhibition. In addition, AXL- and SAM68-deficiency or R428 treatment induced elevated levels of cholesterol and upregulated genes in the cholesterol biosynthesis pathway. There might be a protective role of cholesterol in shielding cancer cells against DNA damage induced by AXL inhibition or SMA68 deficiency.</jats:p> | |
dc.publisher | Springer Science and Business Media LLC | |
dc.source | Elements | |
dc.type | Article | |
dc.date.updated | 2023-06-30T02:35:14Z | |
dc.contributor.department | BIOCHEMISTRY | |
dc.contributor.department | CANCER SCIENCE INSTITUTE OF SINGAPORE | |
dc.contributor.department | MEDICINE | |
dc.contributor.department | PHYSICS | |
dc.description.doi | 10.1038/s42003-023-05045-0 | |
dc.description.sourcetitle | Communications Biology | |
dc.description.volume | 6 | |
dc.description.issue | 1 | |
dc.published.state | Published | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
s42003-023-05045-0.pdf | 6.28 MB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.